Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263819 · ClinicalTrials.gov registry record
Gastrointestinal Symptoms in Postural Orthostatic Tachycardia Syndrome
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 26
- Enrollment target
NCT03263819 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 26 participants.
The verdict
NCT03263819 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Patients with POTS experience significant gastrointestinal symptoms. Current evidence suggesting that abnormal post-ganglionic sympathetic function could play a role in the pathophysiology of these GI abnormalities. Sympathetic fiber regulate motor and the postprandial GI peptides secretion. The focus of the present proposal is to determine glucose homeostasis, GI motility, and their association with GI and cardiovascular symptoms in POTS patients versus healthy controls. Furthermore, we will determine differences in these outcomes in POTS patients with and without evidence of postganglionic sympathetic fiber neuropathy. As a long-term goal, this study can lead us to understand the pathophysiology of common co-morbidities in patients with POTS to provide new treatment approaches and prevention strategies.
Interventions
- DIAGNOSTIC_TEST Oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2017-06-20 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03263819
The ClinicalTrials.gov registry entry for NCT03263819 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral glucose tolerance test is the first listed.
NCT03263819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03263819 about?
NCT03263819 is a clinical study titled "Gastrointestinal Symptoms in Postural Orthostatic Tachycardia Syndrome". Patients with POTS experience significant gastrointestinal symptoms. Current evidence suggesting that abnormal post-ganglionic sympathetic function could play a role in the pathophysiology of these GI abnormalities. Sympathetic fiber regulate motor and the postprandial GI peptides secretion. The fo...
What is the current status of trial NCT03263819?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2017-06-20. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03263819?
The interventions under investigation include: Oral glucose tolerance test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03263819?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.